New approach for drug susceptibility testing: Monitoring the stress response of mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4598-4603

  Rieder, Ronald J ^a   Zhao, Zhihui ^a   Zavizion, Boris ^a  

^a BioSense Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; DIELECTRIC CONSTANT; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRESS;

ELECTRIC IMPEDANCE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; STRESS, PHYSIOLOGICAL;

EID: 70350329360     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00643-09     Document Type: Article

References (29)

1. Aersten, A., and C. W. Michiels. 2005. Diversity or die: generation of diversity in response to stress. Crit. Rev. Microbiol. 31:69-78.
2. Centers for Disease Control and Prevention. 1993. Tuberculosis control laws - United States, 1993. MMWR Recommend. Rep. 42(RR-15):1-28.
3. Chung, G. A. C., Z. Aktar, S. Jackson, and K. Duncan. 1995. High-throughput screen for detecting antimycobacterial agents. Antimicrob. Agents Chemother. 39:2235-2238.
4. Davies, A. P., O. J. Billington, T. D. McHugh, D. A. Mitshison, and S. H. Gillespie. 2000. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3686-3688.
5. Erill, I., S. Campoy, and J. Barbé. 2007. Aeons of distress: an evolutionary perspective on the bacterial SOS response. FEMS Microbiol. Rev. 31:637-656.
6. Ferenci, T., and B. Spira. 2007. Variation in stress responses within a bacterial species and the indirect costs of stress resistance. Ann. N. Y. Acad. Sci. 1113:105-113.
7. Giuliodori, A. M., C. O. Gualerzi, S. Soto, J. Vila, and M. M. Tavio. 2007. Review on bacterial stress topics. Ann. N. Y. Acad. Sci. 1113:95-104.
8. Goh, E. B., G. Yim, W. Tsui, J. McClure, M. G. Surette, and J. Davis. 2002. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl. Acad. Sci. USA 99:17025-17030.
9. Iseman, M. D. 2002. Tuberculosis therapy: past, present and future. Eur. Respir. J. 20:87S-94S.
10. Kosagöz, T., C. I. Hackbarth, I. Ü nsal, E. Y. Rosenberg, H. Nikaido, and H. F. Chambers. 1996. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40:1768-1774.
11. LaBombardi, V. J. 2002. Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide. J. Clin. Microbiol. 40:2238-2239.
12. Marles-Wright, J., and R. J. Lewis. 2007. Stress response of bacteria. Curr. Opin. Struct. Biol. 17:755-760.
13. Miller, M. A., L. Thibert, F. Desjardins, S. H. Siddiqi, and A. Dascal. 1996. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test. J. Clin. Microbiol. 34:84-86.
14. Orenstein, E. V., S. Basu, N. S. Shah, J. R. Andrews, G. H. Friedland, A. P. Moll, N. R. Gandhi, and A. P. Galvani. 2009. Treatment outcomes among patients with multidrug-resistant tuberculosis: review and meta-analysis. Lancet Infect. Dis. 9:153-161.
15. Provvedi, R., F. Boldrin, F. Falciani, G. Palu, and R. Manganelli. 2009. Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 155:1093-1102.
16. Raviglione, M. C., and I. M. Smith. 2007. XDR tuberculosis - implications for global public health. N. Engl. J. Med. 356:656-659.
17. Rieder, R. J., J. R. Howatt, E. Rubin, A. Sloutsky, L. Wu, and B. Zavizion. 2007. A new rapid method for the drug susceptibility testing of mycobacteria, 2007, poster P4. NFID Annu. Conf. Antimicrob. Resist.
18. Rieder, R. J., and B. Zavizion. 2007. Stress response monitoring: a new approach for rapid bacterial detection and susceptibility testing, abstr. I-069. Abstr. 107th Gen. Meet. Am. Society Microbiol. American Society for Microbiology, Washington, DC.
19. Sekiguchi, J., T. Miyoshi-Akiyama, E. Augustynowicz-Kopeć, Z. Zwolska, F. Kirikae, E. Toyota, I. Kobayashi, K. Morita, S. K. K. Kudo, T. Kuratsuji, T. Mori, and T. Kirikae. 2007. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:179-192.
20. Shi, R., N. Itagaki, and I. Sugawara. 2007. Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. Mini Rev. Med. Chem. 7:1177-1185.
21. Shinnick, T. M., M. F. Iademarco, and J. C. Ridderhof. 2005. National plan for reliable tuberculosis laboratory services using a systems approach. MMWR Recommend. Rep. 54(RR-6):1-12.
22. Siddiqi, S., P. Takhar, C. Baldeviano, W. Glover, and Y. Zhang. 2007. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51:2100-2104.
23. Spradlign, P., D. Drociuk, S. McLaughlin, L. M. Lee, C. A. Peloquin, K. Gallicano, C. Pozsik, I. Onorato, K. G. Castro, and R. Ridzon. 2002. Drugdrug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak. Clin. Infect. Dis. 35:1106-1112.
24. Storla, D. G., S. Yimer, and G. A. Bjune. 2008. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8:15-24.
25. Van Klingeren, B., M. Dessens-Kroon, T. van der Laan, K. Kremer, and D. van Soolingen. 2007. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J. Clin. Microbiol. 45:2662-2668.
26. Wallace, R. J., D. R. Nash, L. C. Steele, and V. Steingrube. 1986. Susceptibility of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol. 24:976-981.
27. WHO. 1998. Laboratory services in tuberculosis control. Part II. Culture. WHO, Geneva, Switzerland. http://www.phppo.cdc.gov/dls/ila/documents/lstc3.pdf.
28. Yim, G., F. de la Cruz, G. B. Spiegelman, and J. Davies. 2006. Transcription modulation of Salmonella enterica serovar Typhimurium promoters by sub-MIC levels of rifampin. J. Bacteriol. 188:7988-7991.
29. Zhang, Y., S. Permar, and Z. Sun. 2002. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol. 51:42-49.